analyzed the significantly elevated glutameta concentration in tumor tissues of tumor-bearing mice, which was approximately 27 times higher than that in adjacent tissues [175]
Hoevenaars FPM, Wopereis S, Plugues M, La Terra P, Batchnarova N
The evidence base is preclinical: findings come from animal and in-vitro models, and BPC-157 is not approved for human or veterinary use
One trial evaluated TB4 for heart health, finding that the peptide could protect and repair the heart in patients with acute myocardial infarction, and a separate trial found that TB4 improved outcomes during congenital heart surgery.21 The review also mentions a few clinical trials related to eye health, with results showing that TB4 can reduce eye dryness, relieve ocular discomfort, lower inflammation in the conjunctiva, and more
Oral GHK-Cu dosing research considers bioavailability differently than injectable research, because oral administration involves gastrointestinal processing before systemic distribution
The Road Ahead
